Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
236.5 USD | +0.50% | +3.37% | +0.13% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.13% | 12.08B | |
+21.51% | 46.81B | |
-1.05% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.07% | 26.06B | |
-19.37% | 19.13B | |
+32.20% | 12.39B | |
+0.13% | 11.96B | |
+20.65% | 11.56B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International : Citigroup Adjusts Price Target on Charles River Laboratories International to $355 From $350, Maintains Neutral Rating